Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
Charles River Laboratories to Host Virtual Investor Day
04:30pm, Wednesday, 26'th May 2021
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #investorday--Charles River Laboratories to Host Virtual Investor Day
Charles River Acquires Viral Vector Player For $350M
01:16pm, Monday, 17'th May 2021
Contract researcher Charles River Laboratories International Inc (NYSE: CRL) will dole out $292.5 million for gene therapy CDMO Vigene Biosciences with the possibility for an additional $57.5 mill
Charles River (CRAI) Beats on Q1 Earnings, Ups '21 Guidance
09:01am, Wednesday, 12'th May 2021
Charles River's (CRAI) first-quarter 2021 earnings and revenues improve year over year.
Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q1 2021 Results - Earnings Call Transcript
04:43pm, Tuesday, 04'th May 2021
Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q1 2021 Results - Earnings Call Transcript
Charles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates
09:47am, Tuesday, 04'th May 2021
Charles River (CRL) delivered earnings and revenue surprises of 15.53% and 3.49%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Charles River Laboratories Announces First-Quarter 2021 Results
07:00am, Tuesday, 04'th May 2021
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #earnings--Charles River Laboratories Announces First-Quarter 2021 Results
Charles River Laboratories International Inc (CRL) Corporate Executive VP & CFO David Ross.
04:15pm, Friday, 16'th Apr 2021
Corporate Executive VP & CFO of Charles River Laboratories International Inc (30-Year Financial, Insider Trades) David Ross Smith (insider trades) sold 2,000 shares of CRL on 04/15/2021 at an average
Royce International Premier Fund Buys New Work SE, Learning Technologies Group PLC, NICE.
11:38am, Friday, 16'th Apr 2021
Investment company Royce International Premier Fund (Current Portfolio) buys New Work SE, Learning Technologies Group PLC, NICE Information Service Co, discoverIE Group PLC, OBIC Business Consultants
Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities
08:00am, Tuesday, 06'th Apr 2021
WILMINGTON, Mass. & MONTREAL--(BUSINESS WIRE)---- $CRL #Biopharma--Charles River and Valence Discovery announce strategic partnership to provide clients access to AI-enabled drug design.
Charles River Laboratories Completes the Acquisition of Cognate BioServices
04:15pm, Monday, 29'th Mar 2021
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #acquisition--Charles River Laboratories completes the acquisition of Cognate BioServices.
Charles River Laboratories Announces Closing of Senior Notes Offering
04:30pm, Tuesday, 23'rd Mar 2021
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL--Charles River Laboratories announced that it has closed its previously announced offering of $1 billion of senior notes
ETF Strategies to Hedge Against Inflation
05:26pm, Thursday, 11'th Mar 2021
Here are some ways to protect your portfolio from rising inflation.
Charles River Laboratories Prices $1 Billion of Senior Notes
08:00am, Tuesday, 09'th Mar 2021
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #bondoffering--Charles River Laboratories prices $1 billion of senior notes
Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes
09:15am, Monday, 08'th Mar 2021
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #bondoffering--Charles River Laboratories announces planned offering of $1 billion of senior notes
Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies
08:00am, Thursday, 25'th Feb 2021
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Today, Charles River announced a partnership with Kibur Medical to offer exclusive access to its IMD for in vivo preclincal oncology studies.
